These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 7542489)
1. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable. Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489 [TBL] [Abstract][Full Text] [Related]
2. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid. Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558 [TBL] [Abstract][Full Text] [Related]
3. Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status. Heyes MP; Mefford IN; Quearry BJ; Dedhia M; Lackner A Ann Neurol; 1990 Jun; 27(6):666-75. PubMed ID: 2163238 [TBL] [Abstract][Full Text] [Related]
4. Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. Medana IM; Day NP; Salahifar-Sabet H; Stocker R; Smythe G; Bwanaisa L; Njobvu A; Kayira K; Turner GD; Taylor TE; Hunt NH J Infect Dis; 2003 Sep; 188(6):844-9. PubMed ID: 12964115 [TBL] [Abstract][Full Text] [Related]
5. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788 [TBL] [Abstract][Full Text] [Related]
6. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Sas K; Robotka H; Toldi J; Vécsei L J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670 [TBL] [Abstract][Full Text] [Related]
7. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Bay-Richter C; Linderholm KR; Lim CK; Samuelsson M; Träskman-Bendz L; Guillemin GJ; Erhardt S; Brundin L Brain Behav Immun; 2015 Jan; 43():110-7. PubMed ID: 25124710 [TBL] [Abstract][Full Text] [Related]
8. The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria. Medana IM; Hien TT; Day NP; Phu NH; Mai NT; Chu'ong LV; Chau TT; Taylor A; Salahifar H; Stocker R; Smythe G; Turner GD; Farrar J; White NJ; Hunt NH J Infect Dis; 2002 Mar; 185(5):650-6. PubMed ID: 11865422 [TBL] [Abstract][Full Text] [Related]
9. Neuropharmacology of quinolinic and kynurenic acids. Stone TW Pharmacol Rev; 1993 Sep; 45(3):309-79. PubMed ID: 8248282 [TBL] [Abstract][Full Text] [Related]
10. Kynurenine production and catabolism in fetal sheep with embolized or nonembolized placentas. Nicholls T; Nitsos I; Smythe G; Walker DW Am J Obstet Gynecol; 2001 Oct; 185(4):988-95. PubMed ID: 11641690 [TBL] [Abstract][Full Text] [Related]
12. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation. Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923 [TBL] [Abstract][Full Text] [Related]
14. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients. Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952 [TBL] [Abstract][Full Text] [Related]
15. Increased cerebrospinal fluid quinolinic acid, kynurenic acid, and L-kynurenine in acute septicemia. Heyes MP; Lackner A J Neurochem; 1990 Jul; 55(1):338-41. PubMed ID: 2141357 [TBL] [Abstract][Full Text] [Related]
16. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537 [TBL] [Abstract][Full Text] [Related]
17. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. Schwarcz R; Pellicciari R J Pharmacol Exp Ther; 2002 Oct; 303(1):1-10. PubMed ID: 12235226 [TBL] [Abstract][Full Text] [Related]
18. Central kynurenine pathway shift with age in women. de Bie J; Guest J; Guillemin GJ; Grant R J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548 [TBL] [Abstract][Full Text] [Related]
19. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Saito K; Markey SP; Heyes MP Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184 [TBL] [Abstract][Full Text] [Related]
20. Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa. Frank GK; Kaye WH; Ladenheim EE; McConaha C Appetite; 2001 Aug; 37(1):9-14. PubMed ID: 11562153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]